about
Use of Carnosine for Oxidative Stress Reduction in Different PathologiesMultipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseAlcohol and Viral Hepatitis: Role of Lipid RaftsOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineA Mechanistic Review of Mitophagy and Its Role in Protection against Alcoholic Liver DiseaseAlcoholic liver disease: pathogenesis, management, and novel targets for therapyAlcohol abuse: critical pathophysiological processes and contribution to disease burdenAlcoholic liver disease: pathogenesis and new therapeutic targets.Advances and New Concepts in Alcohol-Induced Organelle Stress, Unfolded Protein Responses and Organ DamageWhole-cell biocatalytic and de novo production of alkanes from free fatty acids in Saccharomyces cerevisiaeMitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome.New therapeutic targets in alcoholic hepatitis.Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionChronic liver inflammation: clinical implications beyond alcoholic liver disease.Ethanol pharmacokinetics in neonates and infantsAcetaldehyde-derived advanced glycation end-products promote alcoholic liver diseaseDietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factorsAldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy.Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism.The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation.Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatmentAlterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers.Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.Protective Effect of Tyrosol and S-Adenosylmethionine against Ethanol-Induced Oxidative Stress of Hepg2 Cells Involves Sirtuin 1, P53 and Erk1/2 Signaling.Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced SteatohepatitisImmune dysfunction in acute alcoholic hepatitis.Molecular targets in the treatment of alcoholic hepatitis.Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases.Biomarkers of exposure and effect in human lymphoblastoid TK6 cells following [13C2]-acetaldehyde exposure.Pathogenesis and Management of Alcoholic Liver Disease.Tobacco Smoke-Induced Hepatic Injury with Steatosis, Inflammation, and Impairments in Insulin and Insulin-Like Growth Factor Signaling.Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats.Alcoholic hepatitis: diagnosis and management in 2012.Clinical and forensic signs related to ethanol abuse: a mechanistic approach.Genetic Contribution to Alcohol Dependence: Investigation of a Heterogeneous German Sample of Individuals with Alcohol Dependence, Chronic Alcoholic Pancreatitis, and Alcohol-Related CirrhosisThe Involvement of Acetaldehyde in Ethanol-Induced Cell Cycle Impairment.Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble?
P2860
Q26767420-63B36B2E-8282-40F7-9A71-A77854D2C4A6Q26769618-44F18D3A-6BC0-4F13-972C-47F3771D4FD4Q26773213-ADD9C306-EFE8-4D86-B222-0CCB038F9C81Q26773384-89459E1D-5697-452E-B017-3C4BE0A7AEDDQ26778940-A3945195-FBF0-48AB-959B-261FAC96C4BDQ26861620-5F1E6CC1-FF55-4CA1-8D6D-643DE2A93ABBQ27010642-8E5D4F3D-12A9-4C29-93A7-6A803B921FFEQ27690220-2484815D-DE97-4E03-9FAE-3539050B61C5Q28082366-6DB295C7-BA97-4EA3-9200-5ADFCFEF0614Q28591056-0FB91AC4-FBD9-4782-B36C-D7551AFA750BQ33626988-D160E10B-7760-4934-AB4F-7B0881D64F12Q33757267-7D82361F-4C91-469B-AB2D-F92FFF20889EQ33831413-1744151D-F1DF-4052-B027-741ECCEC0E0CQ33852213-980000F9-84D0-48D2-880C-00F60D6EFB14Q33907429-5B87BF2A-F0D3-4219-AFE2-E24DCBC673F9Q34408850-6B2A7011-0175-4E01-A106-E761C1B5A454Q34440525-6C895BCE-5D92-465A-BAD3-2F9E671EF2BEQ34905489-1935FD01-159D-45DC-B962-38AACDD191F8Q35025292-C3814E34-3C08-4972-ACD9-5DA6AFFAA70EQ35108275-33890212-B387-41D6-9DB6-EE5591824154Q35117523-8108A9CD-8235-42EF-B663-39459D9E22BBQ35451571-73DC09D6-EAF2-4FAC-A8C0-0246A344BE36Q35527928-432AF33D-AB37-4EFF-AC18-E9C1970CBF94Q35685269-600CF81C-B4D5-4D6E-B148-88C9CC88EC63Q35944938-69750DFE-B84B-4388-9895-6A1B2B8041BCQ36003472-4D34E4FB-9C84-4197-A987-E554D7985969Q36011202-32BD5707-0BF3-4A43-AA41-4A2B318806C9Q36269642-A612F871-03FC-45E1-94CE-E200AA2E6D32Q36351877-A1991618-2AA4-4AF3-84AD-907C8135EDE1Q36402487-24DB8D33-46D5-4DCE-81C2-84671258ED37Q36590615-7B777712-E2A5-4F7D-B0E5-7908B6E57A23Q36769367-05542BAA-49D9-4B45-8B71-0313A37C800DQ37011836-8DC05CEC-01AA-477A-A9A0-4E93245507F4Q37164479-F3B63201-638C-455A-87BA-9F305578D6A8Q37628387-3EDE3FCE-4F00-477F-8CB4-DB7FA85C055CQ38067131-25337BF3-F8EF-4CEE-A076-F24621D65128Q38166021-8F190D6C-2E84-47B5-978F-4A9BE75D67AEQ38675906-1D0F99C0-7DE7-4BD9-9C79-CE483A67514DQ38780823-1906E312-106B-4070-8077-46829E1A7B31Q38788160-59475581-BB66-4B11-A805-99B52C4C2AD4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acetaldehyde adducts in alcoholic liver disease.
@ast
Acetaldehyde adducts in alcoholic liver disease.
@en
Acetaldehyde adducts in alcoholic liver disease.
@nl
type
label
Acetaldehyde adducts in alcoholic liver disease.
@ast
Acetaldehyde adducts in alcoholic liver disease.
@en
Acetaldehyde adducts in alcoholic liver disease.
@nl
prefLabel
Acetaldehyde adducts in alcoholic liver disease.
@ast
Acetaldehyde adducts in alcoholic liver disease.
@en
Acetaldehyde adducts in alcoholic liver disease.
@nl
P2093
P2860
P921
P356
P1476
Acetaldehyde adducts in alcoholic liver disease.
@en
P2093
Jack R Wands
Mashiko Setshedi
Suzanne M de la Monte
P2860
P304
P356
10.4161/OXIM.3.3.12288
P577
2010-05-01T00:00:00Z